Optimizing Care Transitions in Multiple Myeloma: Bridging Academic and Community Practices for Bispecific Antibody Therapy : Episode 5

When Is the Right Time? Navigating Key Moments for Referring Multiple Myeloma Patients to an Academic Center

October 18, 2024

By Cesar Rodriguez Valdes, MD
Binod Dhakal, MD, MS

Opinion

Video

Panelists discuss how the initial process of identifying and referring potential candidates for bispecific therapy from the community setting to an academic center involves careful patient assessment, clear communication channels, and established referral protocols to ensure timely and appropriate treatment initiation.

EP: 1.The Power of Partnership: Enhancing Patient Care in Multiple Myeloma through Academic and Community Physician Collaboration

EP: 2.Fast-Tracking Care: Streamlining Referrals for Quicker Treatment in Multiple Myeloma

EP: 3.Collaborative Care vs. Independent Treatment: Does It Impact Patient Outcomes in Multiple Myeloma?

EP: 4.Overcoming Challenges in Patient Referrals: Handling Reluctance and Navigating Barriers to Academic Care

Now Viewing

EP: 5.When Is the Right Time? Navigating Key Moments for Referring Multiple Myeloma Patients to an Academic Center

EP: 6.Identifying and Referring Candidates for Bispecific Therapy: Key Factors in Transitioning from Community to Academic Care

EP: 7.Navigating the Challenges: Transitioning Patients from Community to Academic Settings in Multiple Myeloma Care

EP: 8.Inside the Academic Approach: How Initial Consultations for Bispecific Therapy Referrals Are Handled

EP: 9.Comparing Dosing and Management of BCMA vs Non-BCMA Bispecific Antibodies

EP: 10.Management of Bispecifc AE’s in the Community Setting of Multiple Myeloma Patients

EP: 11.Criteria for Transitioning Patients from Bispecific Therapy to Community Oncologist Care in Multiple Myeloma

EP: 12.Protocols for Monitoring and Managing Long-Term Complications of Bispecific Therapy in Mutlplie Myeloma

EP: 13.Enhancing Communication Between Academic and Community Oncologists During Referral and Treatment in Multiple Myeloma.

EP: 14.Optimizing Patient Reintegration into Community Care Post-Academic Treatment of Bispecifics in Multiple Myeloma

EP: 15.Unmet Needs and Future Directions for Enhancing Bispecific Therapy Care Transitions in Multiple Myeloma

Video content above is prompted by the following:

Could you describe the initial process of identifying and referring potential candidates for bispecific therapy from the community setting to an academic center?

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!